ConductScience.org, home

Paper7579784

Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.

Dunn CJ and 1 other. Drugs Aging, 1995. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients. Papers, record 7579784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7579784

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.
PubMed
Journal
Drugs Aging
PubMed
Year
1995
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.3
iCite
Revised in PubMed
2026-10-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dunn CJC J
2Wagstaff AJA J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnemiaMajor topic
ErythropoietinMajor topic
Kidney Failure, ChronicMajor topic
Postoperative ComplicationsMajor topic
Adolescent
Adult
Aged
Chronic Disease
Humans
Middle Aged
Recombinant Proteins

Source PubMed

Download CSV of topics

References169

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11785666Erythropoietin. Biology and clinical applications.Am J Pediatr Hematol Oncol1991https://conductscience.org/library/papers/1785666PubMed
22378790The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2378790PubMed
31528712Is Recormon less painful than Eprex after subcutaneous administration?Pharm Weekbl Sci1992https://conductscience.org/library/papers/1528712PubMed
48418709Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery.Anesth Analg1993https://conductscience.org/library/papers/8418709PubMed
57510197Hematopoietic growth factor therapy of myelodysplastic syndromes.Leuk Lymphoma1993https://conductscience.org/library/papers/7510197PubMed
67839070R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis.Rheumatol Int1994https://conductscience.org/library/papers/7839070PubMed
71928084Effects of erythropoietin on blood pressure.Am J Kidney Dis1991https://conductscience.org/library/papers/1928084PubMed
82342535Erythropoietin treatment of anemia associated with multiple myeloma.N Engl J Med1990https://conductscience.org/library/papers/2342535PubMed
97644114The future of r-HuEPO.Nephrol Dial Transplant1995https://conductscience.org/library/papers/7644114PubMed
108427776Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study.Br J Cancer1993https://conductscience.org/library/papers/8427776PubMed
117852220Clinical application of recombinant erythropoietin in myelodysplasia.Hematol Oncol Clin North Am1994https://conductscience.org/library/papers/7852220PubMed
122349956Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.Am J Nephrol1990https://conductscience.org/library/papers/2349956PubMed
131928085Side effects of erythropoietin therapy.Am J Kidney Dis1991https://conductscience.org/library/papers/1928085PubMed
148356412Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation.Scand J Rheumatol1993https://conductscience.org/library/papers/8356412PubMed
158485205Serial changes in endogenous erythropoietin levels in patients with myelodysplastic syndromes and aplastic anemia undergoing erythropoietin treatment.Ann Hematol1993https://conductscience.org/library/papers/8485205PubMed
168302403Effects of erythropoietin administration on prolactin secretion in normal subjects.Nephron1993https://conductscience.org/library/papers/8302403PubMed
172048574Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Canadian Erythropoietin Study Group.Am J Nephrol1991https://conductscience.org/library/papers/2048574PubMed
183056862Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.Int J Artif Organs1988https://conductscience.org/library/papers/3056862PubMed
191543779Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemia.Perit Dial Int1992https://conductscience.org/library/papers/1543779PubMed
208262840Erythropoietin increases hemoglobin in cancer patients during radiation therapy.Int J Radiat Oncol Biol Phys1993https://conductscience.org/library/papers/8262840PubMed

See all 169 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
33213494Does subcutaneous administration of recombinant human erythropoietin increase thrombotic events in total hip arthroplasty? A prospective thrombelastography analysis.J Orthop Surg Res2020https://conductscience.org/library/papers/33213494PubMed
32188052Lysophosphatidic Acid and Hematopoiesis: From Microenvironmental Effects to Intracellular Signaling.Int J Mol Sci2020https://conductscience.org/library/papers/32188052PubMed
11735636Darbepoetin alfa.Drugs2001https://conductscience.org/library/papers/11735636PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EPO2056PubTator's text mininghttps://conductscience.org/library/genes/2056

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7579784

GET https://conductscience.org/api/papers/v1/7579784/references?page=2